+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ovarian"

Uterine Fibroids - Pipeline Insight, 2025 - Product Thumbnail Image

Uterine Fibroids - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Polycystic Ovary Syndrome- Pipeline Insight, 2025 - Product Thumbnail Image

Polycystic Ovary Syndrome- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
Uterine Fibroids Pipeline Analysis Report - Product Thumbnail Image

Uterine Fibroids Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
From
From
From
Female Infertility: Epidemiology Forecast to 2033 - Product Thumbnail Image

Female Infertility: Epidemiology Forecast to 2033

  • Report
  • June 2024
  • 38 Pages
  • Global
From
From
From
Gynaecology Drugs Market Report 2023-2033 - Product Thumbnail Image

Gynaecology Drugs Market Report 2023-2033

  • Report
  • February 2023
  • 340 Pages
  • Global
From
From
From
Loading Indicator

The Ovarian market is a segment of the Women's Health industry that focuses on the diagnosis, treatment, and prevention of ovarian diseases. It includes products and services related to the diagnosis, treatment, and prevention of ovarian cancer, ovarian cysts, and other ovarian disorders. The market also includes products and services related to fertility, contraception, and hormone replacement therapy. The Ovarian market is driven by the increasing prevalence of ovarian diseases, the growing awareness of the importance of early diagnosis and treatment, and the increasing demand for fertility treatments. Additionally, the development of new technologies and treatments for ovarian diseases is expected to drive the market growth. Some companies in the Ovarian market include AbbVie, AstraZeneca, Bayer, Merck, Novartis, Pfizer, and Roche. Show Less Read more